Rakshit Drugs Pvt Ltd, Hyderabad, India is the largest manufacturer of Diminazene Daceturate API. From last 20 years, Rakshit is manufacturing Diminazene Daceturate & other APIs. Rakshit has 5 cGMP compliance factories with high volume equipment to manufacture Diminazene Daceturate in large bulk quantity. Rakshit is well established and reputed Diminazene Daceturate API Manufacturer, Supplier & Exporter to all major global markets including highly regulated Europe, Japan, Korea, & also to South America, Asia, Middle East and CIS. Rakshit manufactures Diminazene Daceturate USP, EP and IP pharmacopeia. Rakshit facilities are approved by the reputed regulatory authorities like, USFDA, Japan PMDA, Korea-MFDS, CDSCO-India, Mexico-Cofepris and also has approved CEP for several API’s. Rakshit facilities have obtained certifications of WHO-GMP & Europe-WC (Written Confirmation).
Rakshit is leader in manufacturing and supplying Flunixin Meglumine to the domestic market and a leader in exporting to the global market. Many pharmaceutical generic companies who market Diminazene Daceturate FDF in any form of Tablets/Capsules/Gel) are using or buying Diminazene Daceturate manufactured by Rakshit.
Diminazene diaceturate that is used to treat trypanosomiasis and babesiosis. Rakshit drugs is a fully developed API manufacturer. In the year 2000, the company was established and manufacturer of critical APIs and intermediates for global markets.
Cattle and small ruminants are the most common recipients of this drug. Controlling the neuron population may help contain the disease. Several forms of insecticides may be used for prophylaxis. Triatomine vectors have been shown to be killed by drugs in the isoxazoline family. Dogs should not be allowed to consume potentially infectious material. Pharmaceutical Company in Hyderabad.